Elevated Levels of MMP-9 in Untreated Patients with Stage I Essential Hypertension

被引:10
作者
Gkaliagkousi, Eugenia [1 ]
Doumas, Michail [1 ]
Gavriilaki, Eleni [1 ]
Triantafyllou, Areti [1 ]
Vogiatzis, Konstantinos [1 ]
Anyfanti, Panagiota [1 ]
Petidis, Konstantinos [1 ]
Douma, Stella [1 ]
机构
[1] Hippokrateion Hosp, Propedeut Dept Internal Med 2, Thessaloniki, Greece
关键词
metalloproteinases; MMP-2; MMP-9; TIMP-1; essential hypertension; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; ARTERIAL STIFFNESS; PLASMA MATRIX-METALLOPROTEINASE-9; CARDIOVASCULAR RISK; CD40; LIGAND; INTERLEUKIN-6; ASSOCIATION; EXPRESSION; COLLAGEN;
D O I
10.3109/10641963.2012.681726
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increased expression and activity of metalloproteinases have been implicated in the pathophysiology of vascular remodeling and in the growth of atherosclerotic lesions. We aimed at determining the levels of MMP-2, MMP-9, their specific inhibitors TIMP-2 and TIMP-1, and the inflammatory cytokines IL-6 and TNF-alpha, which are related to the stimulation of MMPs, in patients with untreated mild essential hypertension (UH) and normotensive (NT) volunteers. Serum MMP-9 and TIMP-1 levels were significantly different in UH volunteers when compared to NT volunteers. Thus, MMP-9 is elevated in the early stages of essential hypertension and may be used as a marker of cardiovascular risk and vascular dysfunction.
引用
收藏
页码:561 / 566
页数:6
相关论文
共 31 条
[1]   Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension [J].
Bautista, LE ;
Vera, LM ;
Arenas, IA ;
Gamarra, G .
JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (02) :149-154
[2]   Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Poirier, O ;
Bickel, C ;
Smieja, M ;
Hafner, G ;
Meyer, J ;
Cambien, F ;
Tiret, L .
CIRCULATION, 2003, 107 (12) :1579-1585
[3]   Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris [J].
Fukuda, D ;
Shimada, K ;
Tanaka, A ;
Kusuyama, T ;
Yamashita, H ;
Ehara, S ;
Nakamura, Y ;
Kawarabayashi, T ;
Iida, H ;
Yoshiyama, M ;
Yoshikawa, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (02) :175-180
[4]  
GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501
[5]   INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GALIS, ZS ;
SUKHOVA, GK ;
LARK, MW ;
LIBBY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503
[6]   Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly [J].
Galis, ZS ;
Khatri, JJ .
CIRCULATION RESEARCH, 2002, 90 (03) :251-262
[7]   MACROPHAGE FOAM CELLS FROM EXPERIMENTAL ATHEROMA CONSTITUTIVELY PRODUCE MATRIX-DEGRADING PROTEINASES [J].
GALIS, ZS ;
SUKHOVA, GK ;
KRANZHOFER, R ;
CLARK, S ;
LIBBY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :402-406
[8]   Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes [J].
Kai, HK ;
Ikeda, H ;
Yasukawa, H ;
Kai, M ;
Seki, Y ;
Kuwahara, F ;
Ueno, T ;
Sugi, K ;
Imaizumi, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (02) :368-372
[9]   Expert consensus document on arterial stiffness: methodological issues and clinical applications [J].
Laurent, Stephane ;
Cockcroft, John ;
Van Bortel, Luc ;
Boutouyrie, Pierre ;
Giannattasio, Cristina ;
Hayoz, Daniel ;
Pannier, Bruno ;
Vlachopoulos, Charalambos ;
Wilkinson, Ian ;
Struijker-Boudier, Harry .
EUROPEAN HEART JOURNAL, 2006, 27 (21) :2588-2605
[10]   Abnormalities of the extracellular degradation of collagen type I in essential hypertension [J].
Laviades, C ;
Varo, N ;
Fernández, J ;
Mayor, G ;
Gil, MJ ;
Monreal, I ;
Díez, J .
CIRCULATION, 1998, 98 (06) :535-540